This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bronx-Lebanon Selects Allscripts For Revenue Cycle Management

Stocks in this article: MDRX

CHICAGO, March 6, 2013 /PRNewswire/ -- Bronx-Lebanon Hospital Center, a 564 bed not-for-profit health care system serving the South and Central Bronx, New York, selected Sunrise Financial Manager™ (SFM) from Allscripts (NASDAQ: MDRX) to manage revenue across the health care system. Built on the Sunrise Enterprise™ 6.0 platform, SFM will provide Bronx-Lebanon Hospital Center with a modern, integrated clinical and financial system designed for use with the new value-based care payment models.

An early adopter of SFM in the New York City market, Bronx-Lebanon Hospital Center shared valuable insights during solution development, including the importance of addressing changing regulations in healthcare today. The hospital is expanding on a long-standing relationship with Allscripts and is already a seasoned user of the Sunrise Enterprise suite of solutions.

"We selected Allscripts to build on the success we have seen from Sunrise Clinical Manager," said Steve Anderman, chief operating officer of Bronx-Lebanon Hospital Center. "Sunrise Financial Manager was truly developed with the future in mind and will give us the tools to adapt to change while avoiding any business interruption."

Allscripts designed SFM with the latest Microsoft technology, creating a solution that is cohesive, connected and focused on care coordination across a patient's total health experience. The solution uses a single database with unique visual workflow capabilities, providing a flexible tool to streamline business operations, reduce costs and increase efficiencies.

"Sunrise Financial Manager is a game-changing solution that provides a solid foundation for our clients navigating the current healthcare landscape," said Paul Black, president and chief executive officer of Allscripts. "We look forward to helping Bronx- Lebanon thrive in a world of new value based care payment models."

About Bronx-Lebanon Hospital Center

For more than 120 years, Bronx-Lebanon Hospital Center has provided quality and compassionate health care to those in need, regardless of their ability to pay.  Bronx- Lebanon is now among the largest providers of outpatient services in New York City with over 1 million ambulatory visits annually and maintains the second highest market share in the Bronx. Its Emergency Room is responding to 135,000 visits annually, one of the busiest in New York.

Bronx-Lebanon Hospital Center is also one of the few hospitals in New York that by 2013 will be full computerized, with a complete inpatient and outpatient electronic medical record. In looking to the future, Bronx- Lebanon is directing its efforts towards expanding facilities and adding services in response to the needs of the Bronx community. To learn more about Bronx-Lebanon Hospital Center, please visit www.bronx-leb.org.

About Allscripts

Allscripts (NASDAQ:  MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a  Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit  www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2013 Allscripts Healthcare, LLC. All Rights Reserved.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs